Skip to content

Effects of ciprofol and propofol anesthesia on hemodynamics in laparoscopic sleeve gastrectomy

Effect of ciprofol and propofol anesthesia on hemodynamics in laparoscopic sleeve gastrectomy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068315
Enrollment
Unknown
Registered
2023-02-14
Start date
2023-02-14
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metabolic disorders

Interventions

Group of Ciprofol:The use of Ciprofol during anesthesia induction and maintenance period
Group of propofol:The use of propofol during anesthesia induction and maintenance period

Sponsors

the First Affiliated Hospital of Jinan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Age : 18-60 years ; ( 2 ) Obese patients : body mass index ( BMI ) > 30 kg / m2 ; ( 3 ) ASA grade I ~ II ; ( 4 ) Patients scheduled for elective laparoscopic sleeve gastrectomy under general anesthesia.

Exclusion criteria

Exclusion criteria: ( 1 ) Patients with cardiovascular, respiratory or renal diseases and cortical dysfunction with clinical significance ; ( 2 ) Patients with other expected intubation difficulties and expected difficult airway factors except obesity ; ( 3 ) patients known to be allergic to eggs, soy products or propofol, and patients with contraindications to propofol, opioids and their relievers ; ( 4 ) pregnant and lactating women ; ( 5 ) Family history of malignant hyperthermia ; ( 6 ) patients undergoing general anesthesia within 4 weeks during perioperative period ; ( 7 ) Patients with alcohol or drug abuse within 3 months of perioperative period ; patients who had taken drugs that may affect the QT interval or induce / inhibit P450 or CYP2B6 within 2 weeks of the perioperative period ; ( 8 ) Preoperative examination : QTc interval = 450ms in ECG screening ; personnel with abnormal laboratory measurement results related to cardiopulmonary system during screening ; ( 9 ) Have taken sedatives / anesthetics within 3 days after screening.

Design outcomes

Primary

MeasureTime frame
mean arterial blood pressure;Heart rate;

Secondary

MeasureTime frame
Peripheral capillary oxygen saturation;Anesthetic dosage;sedation scale;score pain;incidence of adverse events;

Countries

CHINA

Contacts

Public ContactLI YA LAN
3352599594@qq.com18928903868

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026